Balleine R L, Murali R, Bilous A M, Farshid G, Waring P, Provan P, Byth K, Thorne H, Kirk J A
Translational Oncology, Sydney West Area Health Service, Sydney, Australia.
Histopathology. 2006 Nov;49(5):523-32. doi: 10.1111/j.1365-2559.2006.02538.x.
Germline variants in the ataxia telangiectasia mutated (ATM) gene have been implicated in increased breast cancer risk. The aim of this study was to determine whether the histopathology of breast cancers occurring in ATM variant carriers is distinctive or resembles the described BRCA1 mutation-associated phenotype.
The histopathological features of breast cancers occurring in ATM variant carriers from multiple-case breast cancer families were compared with matched controls. The test group included 21 cases of in situ and/or invasive cancer from carriers of either the IVS10-6T-->G, 2424V-->G or 1420L-->F ATM variants in the absence of BRCA1 or BRCA2 mutations. An additional four invasive cancers from carriers of a pathogenic BRCA1 mutation in the context of a familial ATM variant were also examined.
The histopathology of breast cancers in ATM variant-only carriers was not significantly different from controls and known features of BRCA1 mutation-associated cancer were rarely seen. In contrast, these features were prominent in the small group of cases with a pathogenic BRCA1 mutation.
Breast cancer occurring in carriers of ATM variants is not associated with distinctive histopathological features and does not resemble the tumour phenotype commonly observed in BRCA1 mutation carriers.
共济失调毛细血管扩张症突变(ATM)基因的种系变异与乳腺癌风险增加有关。本研究的目的是确定ATM变异携带者发生的乳腺癌的组织病理学是否具有独特性或类似于所描述的与BRCA1突变相关的表型。
将多病例乳腺癌家族中ATM变异携带者发生的乳腺癌的组织病理学特征与匹配的对照进行比较。测试组包括21例原位癌和/或浸润癌,这些病例来自IVS10-6T→G、2424V→G或1420L→F ATM变异携带者,且不存在BRCA1或BRCA2突变。还检查了另外4例在家族性ATM变异背景下携带致病性BRCA1突变的携带者的浸润癌。
仅携带ATM变异的携带者发生的乳腺癌的组织病理学与对照无显著差异,很少见到与BRCA1突变相关癌症的已知特征。相比之下,这些特征在一小部分携带致病性BRCA1突变的病例中很突出。
ATM变异携带者发生的乳腺癌与独特的组织病理学特征无关,也不类似于BRCA1突变携带者中常见的肿瘤表型。